Last reviewed · How we verify

Cerazette®

University Hospital, Ghent · FDA-approved active Small molecule

Cerazette is a progestin-only oral contraceptive that prevents pregnancy primarily by thickening cervical mucus and inhibiting ovulation.

Cerazette is a progestin-only oral contraceptive that prevents pregnancy primarily by thickening cervical mucus and inhibiting ovulation. Used for Contraception in women of reproductive age, Contraception in women who cannot use estrogen-containing contraceptives.

At a glance

Generic nameCerazette®
SponsorUniversity Hospital, Ghent
Drug classProgestin-only oral contraceptive (minipill)
TargetProgesterone receptor
ModalitySmall molecule
Therapeutic areaContraception
PhaseFDA-approved

Mechanism of action

Cerazette contains desogestrel, a synthetic progestin that works through multiple mechanisms: it alters cervical mucus consistency to impede sperm penetration, suppresses the luteinizing hormone (LH) surge needed for ovulation, and modifies the endometrium to prevent implantation. Unlike combined oral contraceptives, it contains no estrogen, making it suitable for women who cannot tolerate or are contraindicated for estrogen-containing formulations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: